RPGLF (Regent Pacific Group) Total Liabilities : $4.86 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Regent Pacific Group Total Liabilities?

Regent Pacific Group's Total Liabilities for the quarter that ended in Jun. 2024 was $4.86 Mil.

Regent Pacific Group's quarterly Total Liabilities declined from Jun. 2023 ($5.52 Mil) to Dec. 2023 ($4.35 Mil) but then increased from Dec. 2023 ($4.35 Mil) to Jun. 2024 ($4.86 Mil).

Regent Pacific Group's annual Total Liabilities increased from Dec. 2021 ($23.46 Mil) to Dec. 2022 ($23.72 Mil) but then declined from Dec. 2022 ($23.72 Mil) to Dec. 2023 ($4.35 Mil).

Regent Pacific Group Total Liabilities Historical Data

The historical data trend for Regent Pacific Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regent Pacific Group Total Liabilities Chart

Regent Pacific Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

30.01

23.46

23.72

4.35

6.51

Regent Pacific Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															23.72	5.52	4.35	4.86	6.51

Regent Pacific Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Regent Pacific Group's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.581	+	(0.765	+	1.1102230246252E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	4.35

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2.795	-	-1.551
	=	4.35

Regent Pacific Group's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.612	+	(1.251	+	4.4408920985006E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	4.86

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	0.789	-	-4.074
	=	4.86

Regent Pacific Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of Regent Pacific Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Regent Pacific Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regent Pacific Group Ltd (OTCPK:RPGLF) » Definitions » Total Liabilities

Traded in Other Exchanges

00575:Hong Kong RPG:Germany RPG:Germany

Address

5 Queen's Road Central, 8th Floor, Henley Building, Hong Kong, HKG

Website

https://www.endurancerp.com

Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan.

Regent Pacific Group Headlines

No Headlines